13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q1 2017. See the latest, Q2 2026 →
Reported value
$787.10B
+5.2% on the quarter before
Positions
2,641
165 new · 169 sold out
Top 10
16.7%
of the value
Est. gain
+$48.09B
on stocks held all quarter
Est. return
+7.0%
on those stocks since Q4 2016
Positions as of Mar 31, 2017, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 27% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2016. Striped tiles are options.
Largest buys
Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Amgen Inc~$2.24BAdded · 0.8% → 1.1%+13,622,745 shares
- Citigroup Inc~$972.5MAdded · 0.7% → 0.8%+16,257,931 shares
- British Amern Tob Plc~$881.1MAdded · 0.2% → 0.2%+13,286,046 shares
- Apple~$837.6MAdded · 2.4% → 3.0%+5,830,423 shares
- Snap~$737.1MNew · 0.0% → 0.1%+33,450,285 shares
- Jd Com Inc~$718.8MAdded · 0.1% → 0.2%+23,104,318 shares
- Tesla~$667.9MAdded · 0.6% → 0.9%+2,400,034 shares
- Intel~$618.2MAdded · 0.1% → 0.2%+17,139,450 shares
- Ggp Inc~$590.4MNew · 0.0% → 0.1%+25,471,343 shares
- Marriott Intl Inc New~$579.0MAdded · 0.1% → 0.1%+6,147,789 shares
Largest sells
Since Q4 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Starbucks Corp~$1.34BCut · 0.5% → 0.4%−22,921,770 shares
- Gilead Sciences Inc~$1.11BCut · 0.4% → 0.2%−16,329,195 shares
- Reynolds American Inc~$939.4MCut · 0.2% → 0.1%−14,906,597 shares
- Johnson & Johnson~$886.5MCut · 0.5% → 0.4%−7,117,440 shares
- Nvidia~$871.4MCut · 1.0% → 0.9%−7,999,657 shares
- Teva Pharmaceutical Inds Ltd~$843.2MCut · 0.3% → 0.1%−26,276,489 shares
- Chevron Corp New~$780.3MCut · 0.7% → 0.5%−7,267,616 shares
- Biogen Inc~$726.7MCut · 0.3% → 0.2%−2,657,944 shares
- Nike Inc~$680.3MCut · 0.4% → 0.3%−12,207,052 shares
- Celgene Corp~$650.3MCut · 0.3% → 0.2%−5,226,515 shares
Holdings
As of Mar 31, 2017. Changes are in shares against Dec 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares +3.7% · price +24.0% | 3.0% | $23.53B | +$4.40B | ||||||||
| MetaCL A · shares −1.2% · price +23.5% | 2.4% | $18.67B | +$3.55B | ||||||||
| AmazonCOM · shares −2.3% · price +18.2% | 2.1% | $16.75B | +$2.58B | ||||||||
| AlphabetCAP STK CL A · shares −0.3% · price +7.0% | 1.9% | $14.65B | +$956.4M | ||||||||
| AlphabetCAP STK CL C · shares −1.9% · price +7.5% | 1.5% | $11.54B | +$803.1M | ||||||||
| MicrosoftCOM · shares −1.9% · price +6.0% | 1.5% | $11.45B | +$647.0M | ||||||||
| Unitedhealth Group IncCOM · shares −1.5% · price +2.5% | 1.1% | $9.01B | +$218.1M | ||||||||
| Amgen IncCOM · shares +33% · price +12.2% | 1.1% | $8.93B | +$728.5M | ||||||||
| Jpmorgan Chase & CoCOM · shares +3.5% · price +1.8% | 1.1% | $8.78B | +$149.7M | ||||||||
| Visa Inc.COM CL A · shares −4.1% · price +13.9% | 0.98% | $7.75B | +$946.1M | ||||||||
| Bank Amer CorpCOM · shares +0.7% · price +6.7% | 0.96% | $7.58B | +$475.1M | ||||||||
| Wells Fargo & Co NewCOM · shares −2.3% · price +1.0% | 0.96% | $7.53B | +$74.4M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +0.1% · price +2.3% | 0.93% | $7.30B | +$167.1M | ||||||||
| TeslaCOM · shares +11% · price +30.2% | 0.86% | $6.80B | +$1.42B | ||||||||
| NvidiaCOM · shares −11% · price +2.1% | 0.85% | $6.72B | +$135.0M | ||||||||
| SalesforceCOM · shares −3.3% · price +20.5% | 0.85% | $6.70B | +$1.14B | ||||||||
| Citigroup IncCOM NEW · shares +18% · price +0.7% | 0.80% | $6.33B | +$34.9M | ||||||||
| Activision Blizzard IncCOM · shares +0.5% · price +38.1% | 0.71% | $5.59B | +$1.53B | ||||||||
| Home Depot IncCOM · shares −3.0% · price +9.5% | 0.61% | $4.83B | +$419.2M | ||||||||
| Medtronic PlcSHS · shares −3.1% · price +13.1% | 0.58% | $4.60B | +$532.2M | ||||||||
| Boston Scientific CorpCOM · shares +7.6% · price +15.0% | 0.58% | $4.59B | +$556.0M | ||||||||
| MastercardCL A · shares −5.3% · price +8.9% | 0.57% | $4.51B | +$370.0M | ||||||||
| AdobeCOM · shares +0.4% · price +26.4% | 0.56% | $4.42B | +$920.2M | ||||||||
| Broadcom LtdSHS · shares −2.3% · price +23.9% | 0.53% | $4.18B | +$805.2M | ||||||||
| Chubb LimitedCOM · shares +1.0% · price +3.1% | 0.50% | $3.97B | +$119.2M | ||||||||
| Total · 2,641 positions | 100% | $787.10B | +$48.09B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2016 to Q1 2017: 2,409 stocks held throughout, up $48.09B (+7.0%).
- Apple+$4.40B+24%
- Meta+$3.55B+23%
- Amazon+$2.58B+18%
- Activision Blizzard Inc+$1.53B+38%
- Tesla+$1.42B+30%
- Lululemon Athletica Inc−$250.5M−20%
- Anadarko Pete Corp−$266.3M−11%
- Chevron Corp New−$357.3M−9%
- British Amern Tob Plc−$504.5M−41%
- Qualcomm−$536.5M−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 4 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |